Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.

Tong H, Ren Y, Qian W, Xiao F, Mai W, Meng H, Jin J.

Int J Hematol. 2009 Oct;90(3):303-10. doi: 10.1007/s12185-009-0390-6. Epub 2009 Sep 2.

PMID:
19728028
2.

Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.

Tong H, Ren Y, Liu H, Xiao F, Mai W, Meng H, Qian W, Huang J, Mao L, Tong Y, Wang L, Qian J, Jin J.

Leuk Lymphoma. 2008 Jan;49(1):81-7. doi: 10.1080/10428190701713630.

PMID:
18203016
3.

[Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].

Li QC, Yuan XL, Wang YF, Zou DH, Zhao YZ, Qiu LG.

Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):254-7. Chinese.

PMID:
18361837
4.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
5.

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.

Escalón MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH.

Cancer. 2005 May 15;103(10):2091-8.

6.

[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].

Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y.

Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):469-73. Chinese.

PMID:
19950562
7.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
8.

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

Schmitz N, Trümper L, Ziepert M, Nickelsen M, Ho AD, Metzner B, Peter N, Loeffler M, Rosenwald A, Pfreundschuh M.

Blood. 2010 Nov 4;116(18):3418-25. doi: 10.1182/blood-2010-02-270785. Epub 2010 Jul 21.

9.

Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.

Yong W, Zheng W, Zhu J, Zhang Y, Wei Y, Wang X, Lin N, Xie Y, Xu B, Li J.

Hematol Oncol. 2006 Mar;24(1):28-32.

PMID:
16323259
10.

Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum.

Akagi T, Takahashi N, Yamaguchi K, Ishizawa K, Murai K, Tajima K, Ikeda K, Kameoka Y, Kameoka J, Ito S, Kato Y, Noji H, Shichishima T, Itoh J, Ichinohasama R, Harigae H, Ishida Y, Sawada K.

J Clin Exp Hematop. 2011;51(1):29-35.

11.

[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].

Pan ZH, Huang HQ, Lin XB, Xia YF, Xia ZJ, Peng YL, Cai QQ, Lin TY, Jiang WQ, Guan ZZ.

Ai Zheng. 2005 Dec;24(12):1493-7. Chinese.

PMID:
16351799
12.

[Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].

Yong W, Zheng W, Zhang Y.

Zhonghua Yi Xue Za Zhi. 2001 Jul 10;81(13):773-5. Chinese.

PMID:
11798962
13.

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.

Ai Zheng. 2006 Aug;25(8):1013-8. Chinese.

PMID:
16965685
14.

Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.

Han AR, Lee HR, Park BB, Hwang IG, Park S, Lee SC, Kim K, Lim HY, Ko YH, Kim SH, Kim WS.

Ann Hematol. 2007 Jul;86(7):493-8. Epub 2007 Mar 9.

PMID:
17347847
15.

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM.

Ann Oncol. 2006 Jan;17(1):123-30. Epub 2005 Oct 19.

16.

The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma.

Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM.

Cancer. 2002 May 15;94(10):2738-44.

17.

[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].

Peng YL, Huang HQ, Lin XB, Xia ZJ, Li YH, Wang W, He YJ, Pan ZH, Jiang WQ, Guan ZZ.

Ai Zheng. 2004 Aug;23(8):943-6. Chinese.

PMID:
15301720
18.

Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.

Chen YC, Ho CL, Kao WY, Hwang JM, Sheu LF, Chao TY.

Ann Hematol. 2001 Nov;80(11):647-52.

PMID:
11757723
19.

Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.

Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM.

Ann Oncol. 2004 Oct;15(10):1467-75.

Items per page

Supplemental Content

Write to the Help Desk